with chromosomal or plasmid-encoded extended spectrum β-lactamases presents a world-wide problem of resistance to third generation cephalosporins. Control of these infections rests on (i) monitoring infections with such resistant organisms in an ongoing fashion, (ii) prompt institution of barrier precautions when infected or colonized patients are identified, and (iii) appropriate use of antimicrobials through implementation of antibiotic control programs.

REFERENCES

1. Haley, R. W., Culver, D. H., White, J. W., Morgan, W. M. & Emori, T. G. (1985) Am. J. Epidemiol. 121, 159–167.

2. Scheckler, W. E., Scheibel, W. & Kresge, D. (1991) Am. J. Med. 91, Suppl. 3B, 90S–94S.

3. Emori, T. G., Banerjee, S. N., Culver, D. H., Gaynes, R. P., Horan, T. C., Edwards, J. R., Jarvis, W. R., Tolson, J. S., Henderson, T. S., Martone, W. J., Hughes, J. M. & the National Nosocomial Infections Surveillance System (1991) Am. J. Med. 91, Suppl. 3B, 289S–293S.

4. Moss, A. J., Hamburger, S., Moore, R. M., Jr., Jeng, L. L. & Howie, L. J. (1991) Use of Selected Medical Device Implants in the United States, 1988 (Natl. Cent. Health Statistics, Centers for Disease Control, Atlanta), No. 191.

5. Health Industry Manufacturers Association (1992) Comments to FDA on the Medical Device Tracking Regulation.

6. Survey of Society of Thoracic Surgeons (1992) Ann. Thorac. Surg. Brochure.

7. Horan, T. C., Culver, D. H., Gaynes, R. P., Jarvis, W. R., Edwards, J. R., Reid, C. R. and the National Nosocomial Infections Surveillance System (1993) Infect. Control Hosp. Epidemiol. 14, 73–80.

8. United Network for Organ Sharing (1993) Scientific registry data.

9. Bortin, M. M., Horowitz, M. M. & Rimm, A. A. (1992) Ann. Intern. Med. 116, 505–512.

10. Carlisle, P. S., Gucalp, R. & Wiernik, P. H. (1993) Infect. Control Hosp. Epidemiol. 14, 320–324.

11. Martone, W. J., Gaynes, R. P., Horan, T. C., Emori, T. G. & Jarvis, W. R. (1991) Infect. Control Hosp. Epidemiol. 12, 609–621.

12. Christian, H. A. (1944) The Principles and Practice of Medicine (Appleton–Century, New York), pp. 54–55.

13. Finland, M. (1955) N. Engl. J. Med. 252, 570–580.

14. Neu, H. C. (1992) Science 257, 1064–1073.

15. McGowan, J. E., Jr., Barnes, M. W. & Finland, M. (1975) J. Infect. Dis. 132, 316–335.

16. McGowan, J. E., Jr. (1985) Rev. Infect. Dis. 7, Suppl. 3, S357–S370.

17. Horan, T. C., White, J. W., Jarvis, W. R., Emori, T. G., Culver, D. H., Munn, V. P., Thornsberry, C., Olson, D. R. & Hughes, J. M. (1984) Morbid. Mortal. Wkly. Rep. 35, 1SS, 17SS–29.

18. Banerjee, S. N., Emori, T. G., Culver, D. H., Gaynes, R. P., Jarvis, W. R., Horan, T. C., Edwards, J. R., Tolson, J. S., Henderson, T., Martone, W. J. & the National Nosocomial Infections Surveillance System (1991) Am. J. Med. 91, Suppl. 3B, 86S–89S.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement